Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$9.49 - $14.26 $47,791 - $71,813
5,036 Added 11.79%
47,733 $498,000
Q4 2023

Feb 06, 2024

BUY
$8.89 - $15.36 $60,318 - $104,217
6,785 Added 18.89%
42,697 $645,000
Q2 2023

Aug 04, 2023

SELL
$14.32 - $18.03 $10,740 - $13,522
-750 Reduced 2.05%
35,912 $645,000
Q1 2023

May 05, 2023

SELL
$11.83 - $16.02 $8,434 - $11,422
-713 Reduced 1.91%
36,662 $571,000
Q4 2022

Feb 13, 2023

SELL
$8.91 - $12.35 $161,627 - $224,029
-18,140 Reduced 32.68%
37,375 $461,000
Q2 2022

Aug 05, 2022

BUY
$6.36 - $13.08 $954 - $1,962
150 Added 0.27%
55,515 $363,000
Q4 2021

Feb 07, 2022

BUY
$10.57 - $13.23 $25,209 - $31,553
2,385 Added 4.5%
55,365 $633,000
Q3 2021

Nov 04, 2021

BUY
$11.83 - $15.79 $626,753 - $836,554
52,980 New
52,980 $646,000

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $1.05B
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.